COVADIS Summit IV, August 31st – September 1st2016, Rome
| Schedule: Wednesday August 31, 2016 13:30 – 20:30 | ||
| 1. Introduction to Coronary Vasomotion Disorders International Study Group (COVADIS) Third Summit | ||
| TIME | TOPIC | SPEAKER |
| 1330 – 1335 | Welcome & Introductions | Noel Bairey Merz, US |
| 1335 – 1340 | Summit Objectives | John Beltrame, AU |
| 2. Japanese Coronary Spasm Association Registry | ||
| 1340 – 1410 | Overview, JCS Abstract, and Planned Analyses/Publications | Hiroaki Shimokawa, JP |
| 1410 – 1430 | Discussion | Juan Carlos Kaski, UK |
| 3. Coronary Microvascular Dysfunction Registry | ||
| 1430 – 1445 | Overview and Demonstration of the CMD Registry. Registry Data Quality Review (initial 150-300 subjects) | Peter Ong, DE and Hiroaki Shimokawa, JP |
| 1445 – 1545 | (each Steering Committee member submits 50) | Hiroaki Shimokawa, JP and Steering Committee |
| 1545 – 1615 | BREAK | |
| 1615 – 1700 | CMD Registry Funding | Hiroaki Shimokawa, JP and Ornella Rimoldi, IT |
| 1700 – 1730 | CMD Registry Policy and Procedures | Noel Bairey Merz, US |
| 1730 – 1800 | Panel Discussion: CMD Policy & Procedures | Udo Sechtem, DE |
| 4. Coronary Microvascular Dysfunction in Heart Failure | ||
| 1800 – 1830 | Tako-tsubo Cardiomyopathy and CMD | Abhiram Prasad, UK |
| 1830 – 1900 | HFpEF and CMD | Noel Bairey Merz, US |
| 1900 – 2030 | Dinner | |
| Schedule: Thursday Sep 1, 2016 8:00 – 12:00 | ||
| 5. Coronary Microvascular Dysfunction Therapies (includes 5 min discussion) | ||
| TIME | TOPIC | SPEAKER |
| 0800 – 0815 | Aerobic Exercise | Eileen Handberg, US |
| 0815 – 0830 | Endothelial Modulating Agents – Statins, L-Arg, ACE-I | Juan Carlos Kaski, UK |
| 0830 – 0845 | Nitrates, Calcium Channel Blockers, Ivabradine | Gaetano Lanza, IT |
| 0900 – 0930 | BREAKFAST BREAK and check-out | |
| 0930 – 0945 | Nicorandil & Rho Kinase Inhibitors | Hiroaki Shimokawa, JP |
| 0945 – 1000 | Ranolazine and Xanthine Derivatives | Filippo Crea, Rome, IT |
| 1000 – 1015 | Enhanced External Counter Pulsation (EECP) | K Kronhaus, US |
| 1015 – 1030 | Cardiac Nociception Targets: Tricyclics, Stellate Ganglion Block, Spinal Stimulators, Cognitive Behavioral | Puja Mehta, US |
| 1030 – 1045 | Meta-analysis of Trials in Angina with Normal Coronary Arteries | Raffaele De Caterina, IT |
| 6. Future Directions of COVADIS | ||
| 1045 – 1100 | Is a COVADIS Clinical Trial Possible? | John Beltrame, AU |
| 1100 – 1115 | COVADIS Summit-2017 (Barcelona) Publication Review | Udo Sechtem, DE |
| Steering Committee Writing Group (Thursday Sep 1, 2016 12:00-17:00) | ||
| C. Noel Bairey Merz, US, John Beltrame, AU, Paolo Camici, IT, Filippo Crea, IT, Juan Carlos Kaski, UK, Peter Ong, DE, Udo Sechtem, DE, Hiro Shimokawa, JP. | ||